Liabilities of Legend Biotech Corp from 31 Dec 2019 to 30 Sep 2024

Taxonomy & unit
ifrs-full: USD
Summary
Legend Biotech Corp quarterly Liabilities in USD history and change rate from 31 Dec 2019 to 30 Sep 2024.
  • Legend Biotech Corp Liabilities for the quarter ending 30 Sep 2024 was $619,718,000, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Legend Biotech Corp Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $619,718,000 +$120,020,000 +24% 30 Sep 2024 6-K 12 Nov 2024 2024 Q3
Q2 2024 $639,181,000 +$115,553,000 +22% 30 Jun 2024 6-K 09 Aug 2024 2024 Q2
Q1 2024 $611,048,000 31 Mar 2024 6-K 13 May 2024 2024 Q1
Q4 2023 $597,238,000 +$10,587,000 +1.8% 31 Dec 2023 6-K 12 Nov 2024 2024 Q3
Q3 2023 $499,698,000 30 Sep 2023 6-K 20 Nov 2023 2023 Q3
Q2 2023 $523,628,000 30 Jun 2023 6-K 15 Aug 2023 2023 Q2
Q4 2022 $586,651,000 +$233,130,000 +66% 31 Dec 2022 20-F 19 Mar 2024 2023 FY
Q4 2021 $353,521,000 +$229,199,000 +184% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 $535,206,000 30 Jun 2021 6-K 23 Aug 2021
Q4 2020 $124,322,000 -$286,262,000 -70% 31 Dec 2020 20-F/A 17 Feb 2023 2021 FY
Q4 2019 $410,584,000 31 Dec 2019 20-F 02 Apr 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.